ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

DCE Advisors OK RFAs In Occupational Cancer, H. Pylori

April 1, 1994

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991